Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lifarizine (RS-87476), a calcium-sodium channel antagonist, shows neuroprotective activity in a simplified rat survival model of double vessel occlusion.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $146 | In Stock | |
5 mg | $350 | In Stock | |
10 mg | $530 | In Stock | |
25 mg | $859 | In Stock | |
50 mg | $1,180 | In Stock | |
100 mg | $1,590 | In Stock |
Description | Lifarizine (RS-87476), a calcium-sodium channel antagonist, shows neuroprotective activity in a simplified rat survival model of double vessel occlusion. |
In vivo | Verofylline (0.05 mg/kg; oral; asthma patients) subject tolerance was good at the doses used. Dose-response curves for mean forced expiratory volume in one second, peak expiratory flow rate, and forced expiratory flow at the end of 4 hr were greater after 0.05 mg/kg verofylline than after placebo or higher doses of verofylline. Mean percent change in forced vital capacity remained increased as long as 6 hr after 0.15 mg/kg active drug. Verofylline was not very effective as a bronchodilator at the doses used.[1] |
Alias | RS-87476-000, RS-87476, RS87476, RS 87476-000, RS 87476 |
Molecular Weight | 436.59 |
Formula | C29H32N4 |
Cas No. | 119514-66-8 |
Smiles | C(N1CCN(CC=2NC(=NC2C)C3=CC=C(C)C=C3)CC1)(C4=CC=CC=C4)C5=CC=CC=C5 |
Relative Density. | 1.153 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 5.63 mg/mL (12.88 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.